Humacyte, Inc.·4

Dec 13, 4:06 PM ET

Prichard Heather Ledbetter 4

4 · Humacyte, Inc. · Filed Dec 13, 2022

Insider Transaction Report

Form 4
Period: 2022-12-12
Prichard Heather Ledbetter
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Stock Options (right to buy)

    2022-12-126,5640 total
    Exercise: $1.15From: 2015-12-14Exp: 2022-12-14Common Stock (6,564 underlying)
  • Exercise/Conversion

    Common Stock

    2022-12-12$1.15/sh+6,564$7,5499,189 total

Documents

1 file
  • 4
    wf-form4_167096559281877.xmlPrimary

    FORM 4